Medical Condition News

RSS

School-based program raises awareness about preventing type 2 diabetes

It is well known that type 2 diabetes is largely a preventable chronic disease with proper nutrition, regular physical activity and the maintenance of a healthy body weight. Yet despite growing awareness, the Canadian Diabetes Association (CDA) reports that more than three million Canadians currently have diabetes, with an overwhelming 90% of cases reflecting type 2 diabetes. The CDA also suggests that a child born in the year 2000 has a frightening 1 in 3 chance of developing diabetes.

23 Mar 2010

Epilepsy Foundation's week of activities to be held to raise awareness of epilepsy and seizures

More than 5,000 people are expected to participate in the Epilepsy Foundation's week of activities March 23 through 27 to raise public awareness of epilepsy and seizures, increase funding for programs and research, and empower people with epilepsy to become advocates for better health care.

23 Mar 2010

Researchers investigate link between consumption of high-fructose corn syrup and obesity

A Princeton University research team has demonstrated that all sweeteners are not equal when it comes to weight gain: Rats with access to high-fructose corn syrup gained significantly more weight than those with access to table sugar, even when their overall caloric intake was the same.

23 Mar 2010

Study: Replacing dietary saturated fats with polyunsaturated fatty acids reduces coronary heart disease

A study in this week's PLoS Medicine shows that the replacement of dietary saturated fatty acids with polyunsaturated fatty acids reduces coronary heart disease events, bringing much needed scientific evidence to an issue debated by experts and clinical guidelines.

23 Mar 2010

AF Stat launch "AFib Educator" smartphone app and desktop widget

AF Stat- - a collaboration of healthcare leaders and organizations working to improve the health and well-being of people affected by atrial fibrillation (AFib) - today unveiled the "AFib Educator," a smartphone app and desktop widget to help healthcare practitioners better explain the risks and consequences of the disease to their patients.

23 Mar 2010

Novo Nordisk Foundation donates $160M to University of Copenhagen for metabolic research

The Center will conduct research into Type 2 diabetes, among other diseases, and will acquire the capacities and resources to establish itself as one of the leading international research centers in the world. With 885 million Danish kroner (approx. 160 million US Dollars) from the Novo Nordisk Foundation, a team of 5 leading research scientists will be headhunted by the University to oversee "The Novo Nordisk Foundation Center for Basic Metabolic Research".

From Novo Nordisk 23 Mar 2010

LFA seeks grant proposals from researchers and investigators to help advance in lupus research

The Lupus Foundation of America seeks grant proposals from researchers and investigators to help advance the science and understanding of pediatric lupus, reproductive health issues in people with lupus, and neuropsychiatric lupus, which affects the brain and peripheral nervous system.

23 Mar 2010

Treating RNA segment in wounds may increase protein levels for growth of skin cells

Scientists have determined that chronic wounds might have trouble healing because of the actions of a tiny piece of a molecular structure in cells known as RNA.

23 Mar 2010

Rapidly declining memory in people with cognitive impairment may indicate stage before Alzheimer's disease

Memory and thinking skills may decline rapidly for people who have mild cognitive impairment, which is the stage before Alzheimer's disease when people have mild memory problems but no dementia symptoms, and even more rapidly when dementia begins, which is when Alzheimer's disease is usually diagnosed. The research is published in the March 23, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology.

23 Mar 2010

T1D and IBD may respond to 2-way genetic switch: Study

Pediatric researchers analyzing DNA variations in type 1 diabetes and inflammatory bowel disease have found a complex interplay of genes. Some genes have opposing effects, raising the risk of one disease while protecting against the other. In other cases, a gene variant may act in the same direction, raising the risk for both diseases.

23 Mar 2010

Pfizer's Neurontin to earn 50% patient share in treatment of postherpetic neuralgia: Survey

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a novel formulation of Pfizer's Neurontin that is dosed once a day would earn a 50 percent patient share in the treatment of postherpetic neuralgia, according to surveyed U.S. neurologists.

23 Mar 2010

FC scans can help clinicians predict effects of strokes and other brain injuries

Clinicians may be able to better predict the effects of strokes and other brain injuries by adapting a scanning approach originally developed for study of brain organization, neurologists at Washington University School of Medicine in St. Louis have found.

23 Mar 2010

Adrenal fatigue: Vitamins, supplements may do more harm than good

Taking vitamins or supplements to treat “adrenal fatigue” may do more harm than good, says Todd Nippoldt, M.D., a Mayo Clinic expert in hormone disorders affecting the adrenal glands.

23 Mar 2010

Study: Four risk factors estimated to reduce life expectancy in the U.S.

A study published this week in PLoS Medicine finds that four risk factors - smoking, high blood pressure, high blood sugar and obesity - explain a substantial amount of the disparity in life expectancy amongst the "Eight Americas", which are groups of the US population that can be defined by race, and location and socioeconomic features of counties they live in.

23 Mar 2010

Diabetic Pennsylvanians can reduce risk of complications by following "ABCs" of diabetes

Secretary of Health Everette James reminds diabetic Pennsylvanians to reduce the risk of complications from the disease and improve their quality of life by knowing and following the "ABCs" of diabetes.

23 Mar 2010

Dual-energy CT helps diagnose gout reliably in acute, emergency settings

A medical imaging technique called dual-energy computed tomography (CT) is an effective and reliable way to diagnose gout in the acute, emergency setting, according to a study published in the April issue of the American Journal of Roentgenology. Dual-energy CT is an advanced medical imaging technique that can detect vessels and bones and display them in clear contrast to one another. It enables physicians to diagnose many patients' conditions faster and more accurately as it can better characterize tissue composition better than conventional CT.

23 Mar 2010

Time-released muco-adhesive patch more effective than oral rinse for xerostomia

A newly developed time-released muco-adhesive patch for treating oral health conditions, including the widespread condition of dry mouth (xerostomia), has been shown to be more effective than a leading oral rinse, according to a newly-published study. As increasing segments of the population consume more medications (one of the leading causes of dry mouth), the results of this study could potentially help provide relief for millions of Americans.

23 Mar 2010

Avoiding boomeritis: Tips from Mayo Clinic Women’s HealthSource

Orthopedic surgeons are seeing a wave of exercise-related injuries among baby boomers -- a phenomenon dubbed “boomeritis.”

23 Mar 2010

FDA's ODAC voted to review T315I mutation prior to approval of OMAPRO

ChemGenex Pharmaceuticals Limited announced today that the U.S. Food and Drug Administration’s Oncologic Drugs Advisory Committee voted 7-1 that a validated test to identify the T315I mutation should be reviewed by the FDA prior to approval of OMAPRO™ (omacetaxine mepesuccinate).

23 Mar 2010

Can-Fite BioPharma files patent application for treatment of Uveitis with A3 adenosine receptor ligands

Can-Fite BioPharma Ltd, a biopharmaceutical company, traded on the TASE and developing anti- inflammatory and anti-cancer drugs, announced today the filing of a patent application, in conjunction with the United Stated National Institutes of Health (NIH), for the treatment of Uveitis with its A3 adenosine receptor ligands.

23 Mar 2010

Medical Condition News

School-based program raises awareness about preventing type 2 diabetes

Epilepsy Foundation's week of activities to be held to raise awareness of epilepsy and seizures

Researchers investigate link between consumption of high-fructose corn syrup and obesity

Study: Replacing dietary saturated fats with polyunsaturated fatty acids reduces coronary heart disease

AF Stat launch "AFib Educator" smartphone app and desktop widget

Novo Nordisk Foundation donates $160M to University of Copenhagen for metabolic research

LFA seeks grant proposals from researchers and investigators to help advance in lupus research

Treating RNA segment in wounds may increase protein levels for growth of skin cells

Rapidly declining memory in people with cognitive impairment may indicate stage before Alzheimer's disease

T1D and IBD may respond to 2-way genetic switch: Study

Pfizer's Neurontin to earn 50% patient share in treatment of postherpetic neuralgia: Survey

FC scans can help clinicians predict effects of strokes and other brain injuries

Adrenal fatigue: Vitamins, supplements may do more harm than good

Study: Four risk factors estimated to reduce life expectancy in the U.S.

Diabetic Pennsylvanians can reduce risk of complications by following "ABCs" of diabetes

Dual-energy CT helps diagnose gout reliably in acute, emergency settings

Time-released muco-adhesive patch more effective than oral rinse for xerostomia

Avoiding boomeritis: Tips from Mayo Clinic Women’s HealthSource

FDA's ODAC voted to review T315I mutation prior to approval of OMAPRO

Can-Fite BioPharma files patent application for treatment of Uveitis with A3 adenosine receptor ligands

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News